Skip to main content

Table 4 Probabilistic sensitivity analysis with first-order Monte Carlo simulation

From: Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors

Drugs

Mean ± SD*

Median

Interquartile range

   

5%

95%

Celecoxib

    

Cost

6,198.7 ± 15,507.1

5,016.6

3,653.1

10,795.3

Effectiveness

365.0

315.0

125.0

452.0

Nonselective NSAIDs

    

Cost

6,528.2 ± 6,199.9

5,300.0

2,340.7

14,497.9

Effectiveness

289.0

265.0

84.0

396.0

Acetaminophen

    

Cost

6,994.3 ± 46,583.7

5,721.5

2,292.7

15,994.9

Effectiveness

275.0

259.0

74.0

351.0

  1. *Standard deviation.
  2. Costs are expressed in Mexican pesos and effectiveness is according to number of patients with pain control without adverse events.
  3. NSAIDs, nonsteroidal anti-inflammatory drugs.